

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival


(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that a customer, the Edith Cowan University in Perth, Western Australia, has publi...


Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance


UK Earnings, Trading Statements Calendar - Next 7 Days


Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter


Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma


Angle Submits Positive Test Results For Parsortix System To US FDA


(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measur...